A Phase 1, Double-Blind, Parallel Group Study to Evaluate the Safety and Pharmacokinetics of Quadruple Therapy (Bismuth, Clarithromycin, and Amoxicillin) With TAK-438 Versus Quadruple Therapy With Lansoprazole
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007236/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the safety, tolerability, and pharmacokinetics (PK) of quadruple therapy with
bismuth, clarithromycin, amoxicillin, and TAK-438 versus quadruple therapy with bismuth,
clarithromycin, amoxicillin, and lansoprazole.
提供机构：
Vivli
创建时间：
2021-06-25
